Understanding the Role of Notified Bodies in Europe for Combination Products. NBOp Requirements and Feedback for Manufacturers

11:40am – 12:10pm EST, 10 December 2026 ‐ 30 mins

Foundations of Combination Products in the EU

This presentation will briefly cover the role of notified bodies in Europe and how they fit into the conformity assessment process for combination products. It will focus on integral drug device combinations and the requirements for a Notified Body Opinion (NBOp), including feedback on submissions and common pitfalls to aid better dossier preparation.